Liver clot study seeks to predict recovery in 1,500 patients

NCT ID NCT07473375

Recruiting now Knowledge-focused Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at factors that help blood clots in the main liver vein dissolve in people with liver scarring (cirrhosis) and enlarged stomach veins. Researchers will follow 1,500 patients over time to see what influences clot recovery. The goal is to help doctors and patients better understand and manage this condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver esophageal varices Fibrosis portal hypertension portal hypertension, noncirrhotic portal vein thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS PORTAL HYPERTENSION RELATED TO CIRRHOSIS PORTAL HYPERTENSION, NONCIRRHOTIC PORTAL VEIN THROMBOSIS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Study site
RECRUITING

Shanghai, Shanghai Municipality, 200032, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.